New inhaled TB drug shows promise in early trial
Disease control
Recruiting now
This study tests a new inhaled medicine called RESP30TB in 24 adults recently diagnosed with a common type of lung tuberculosis (TB). The main goal is to see if the drug is safe and can quickly reduce TB bacteria in the lungs. Participants will receive the drug through a nebulize…
Phase: PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated May 17, 2026 14:00 UTC